510(k) Report

510(k) · Cleared

Cleared

PUREtrace™

K153262510(k) TraditionalCleared Feb 7, 2017455-day reviewClass II21 CFR 884.2720

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nemo Healthcare BV · OSP Uterine Electromyographic Monitor

Cleared on Feb 7, 2017 as substantially equivalent to K112390 (Monica Healthcare, Ltd., 2012) after a 455-day review. Its family tree reaches back 3 generations to 1990.

Decided
Feb 7, 2017
Review
455 days
Class
Class II
Product code
OSP
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K900480 (1990). No later device cites it as a predicate yet.

  1. Root · 3 generations backK900480 M1350A Fetal Monitor (Intrapartum)Hewlett-Packard Co. · 1990
  2. 2 generations backK954351 Series 50XMHewlett-Packard GmbH · 1996
  3. 1 generation backK112390 Monica AN24Monica Healthcare, Ltd. · 2012
  4. This deviceK153262 PUREtrace™Nemo Healthcare BV · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K900480M1350A Fetal Monitor (Intrapartum)Hewlett-Packard Co.1990—
−2K954351Series 50XMHewlett-Packard GmbH1996—
−1K112390Monica AN24Monica Healthcare, Ltd.2012—
0 (this device)K153262PUREtrace™Nemo Healthcare BV2017—
FIG. 1 — Lineage of K153262, 1990–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OSP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OSP device

  1. #1 K190798 LaborView™ LV1000 Wireless Electrode Systemscore 0.9 · 4 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K112390Monica AN24
Summary page 4
…II Product code: OSP, uterine electromyographic monitor Predicate Device: Monica Healthcare AN24 (K112390) Device Description: PUREtrace is a device for registering the electrical activity of the uterine muscle (myometrium) of labori…
Monica Healthcare, Ltd.2012—

Also cleared against K112390: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 27 years and passes through 4 companies; a new generation was cleared every 5.7 years on median.
  • None of the 3 ancestors has a recall.
  • 3 other devices also cite its predicate K112390.

How does its category compare?

All OSP devices

OSP Uterine Electromyographic Monitor: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · OSP

1in 2020

2011: 32012: 12013: 12014: 22015: 12017: 12020: 1
2007high 3 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OSP

220in 2011

2011: 220 days median
2007high 220 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OSP

No recall names OSP since 2007.

Adverse event reports per year · OSP

1in 2025

2017: 12019: 22020: 12022: 22023: 12024: 12025: 1
2007high 2 (2019) · low 0 (2007)2025

MAUDE reports naming product code OSP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
2011322000
20121—00
20131—00
20142—00
20151—00
20160—00
20171—01
20180—00
20190—02
20201—01
20210—00
20220—02
20230—01
20240—01
20250—01
20260—0—

What is it indicated for?

PUREtrace™ is an electromyography (EMG) device that non-invasively measures intrapartum uterine activity. PUREtrace™ is indicated for use on women who are at term (≥37 completed weeks), in labor, with singleton pregnancies. The signal is acquired from surface electrodes that are placed on the maternal abdomen. PUREtrace™ is intended for use by healthcare professionals in a clinical setting.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K153262: PUREtrace™.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K153262

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026